The role of MHC class I gene products in SIV infection of macaques

Zachary A. Silver, David Watkins

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

Human immunodeficiency virus (HIV) remains among the most significant public health threats worldwide. Despite three decades of research following the discovery of HIV, a preventive vaccine remains elusive. The study of HIV elite controllers has been crucial to elaborate the genetic and immunologic determinants that underlie control of HIV replication. Coordinated studies of elite control in humans have, however, been limited by variability among infecting viral strains, host genotype, and the uncertainty of the timing and route of infection. In this review, we discuss the role of nonhuman primate (NHP) models for the elucidation of the immunologic correlates that underlie control of AIDS virus replication. We discuss the importance of major histocompatibility complex class I (MHC-I) alleles in activating CD8+ T-cell populations that promote control of both HIV and simian immunodeficiency virus (SIV) replication. Provocatively, we make the argument that T-cell subsets recognizing the HIV/SIV viral infectivity factor (Vif) protein may be crucial for control of viral replication. We hope that this review demonstrates how an in-depth understanding of the MHC-I gene products associated with elite control of HIV/SIV, and the epitopes that they present, can provide researchers with a glimpse into the protective immune responses that underlie AIDS nonprogression.

Original languageEnglish (US)
Pages (from-to)511-519
Number of pages9
JournalImmunogenetics
Volume69
Issue number8-9
DOIs
StatePublished - Aug 1 2017

Fingerprint

MHC Class I Genes
Simian Immunodeficiency Virus
Macaca
Virus Diseases
HIV
Virus Replication
Major Histocompatibility Complex
Immunological Models
Population Control
T-Lymphocyte Subsets
Primates
Uncertainty
Epitopes
Acquired Immunodeficiency Syndrome
Vaccines
Public Health
Alleles
Genotype
Research Personnel
T-Lymphocytes

Keywords

  • Cytotoxic T lymphocyte (CTL)
  • Human immunodeficiency virus (HIV)
  • Major histocompatibility complex (MHC)
  • Nonhuman primate (NHP) model for AIDS
  • Simian immunodeficiency virus (SIV)

ASJC Scopus subject areas

  • Immunology
  • Genetics

Cite this

The role of MHC class I gene products in SIV infection of macaques. / Silver, Zachary A.; Watkins, David.

In: Immunogenetics, Vol. 69, No. 8-9, 01.08.2017, p. 511-519.

Research output: Contribution to journalReview article

Silver, Zachary A. ; Watkins, David. / The role of MHC class I gene products in SIV infection of macaques. In: Immunogenetics. 2017 ; Vol. 69, No. 8-9. pp. 511-519.
@article{896753688aad4b3ab61136e8279f3674,
title = "The role of MHC class I gene products in SIV infection of macaques",
abstract = "Human immunodeficiency virus (HIV) remains among the most significant public health threats worldwide. Despite three decades of research following the discovery of HIV, a preventive vaccine remains elusive. The study of HIV elite controllers has been crucial to elaborate the genetic and immunologic determinants that underlie control of HIV replication. Coordinated studies of elite control in humans have, however, been limited by variability among infecting viral strains, host genotype, and the uncertainty of the timing and route of infection. In this review, we discuss the role of nonhuman primate (NHP) models for the elucidation of the immunologic correlates that underlie control of AIDS virus replication. We discuss the importance of major histocompatibility complex class I (MHC-I) alleles in activating CD8+ T-cell populations that promote control of both HIV and simian immunodeficiency virus (SIV) replication. Provocatively, we make the argument that T-cell subsets recognizing the HIV/SIV viral infectivity factor (Vif) protein may be crucial for control of viral replication. We hope that this review demonstrates how an in-depth understanding of the MHC-I gene products associated with elite control of HIV/SIV, and the epitopes that they present, can provide researchers with a glimpse into the protective immune responses that underlie AIDS nonprogression.",
keywords = "Cytotoxic T lymphocyte (CTL), Human immunodeficiency virus (HIV), Major histocompatibility complex (MHC), Nonhuman primate (NHP) model for AIDS, Simian immunodeficiency virus (SIV)",
author = "Silver, {Zachary A.} and David Watkins",
year = "2017",
month = "8",
day = "1",
doi = "10.1007/s00251-017-0997-3",
language = "English (US)",
volume = "69",
pages = "511--519",
journal = "Immunogenetics",
issn = "0093-7711",
publisher = "Springer Verlag",
number = "8-9",

}

TY - JOUR

T1 - The role of MHC class I gene products in SIV infection of macaques

AU - Silver, Zachary A.

AU - Watkins, David

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Human immunodeficiency virus (HIV) remains among the most significant public health threats worldwide. Despite three decades of research following the discovery of HIV, a preventive vaccine remains elusive. The study of HIV elite controllers has been crucial to elaborate the genetic and immunologic determinants that underlie control of HIV replication. Coordinated studies of elite control in humans have, however, been limited by variability among infecting viral strains, host genotype, and the uncertainty of the timing and route of infection. In this review, we discuss the role of nonhuman primate (NHP) models for the elucidation of the immunologic correlates that underlie control of AIDS virus replication. We discuss the importance of major histocompatibility complex class I (MHC-I) alleles in activating CD8+ T-cell populations that promote control of both HIV and simian immunodeficiency virus (SIV) replication. Provocatively, we make the argument that T-cell subsets recognizing the HIV/SIV viral infectivity factor (Vif) protein may be crucial for control of viral replication. We hope that this review demonstrates how an in-depth understanding of the MHC-I gene products associated with elite control of HIV/SIV, and the epitopes that they present, can provide researchers with a glimpse into the protective immune responses that underlie AIDS nonprogression.

AB - Human immunodeficiency virus (HIV) remains among the most significant public health threats worldwide. Despite three decades of research following the discovery of HIV, a preventive vaccine remains elusive. The study of HIV elite controllers has been crucial to elaborate the genetic and immunologic determinants that underlie control of HIV replication. Coordinated studies of elite control in humans have, however, been limited by variability among infecting viral strains, host genotype, and the uncertainty of the timing and route of infection. In this review, we discuss the role of nonhuman primate (NHP) models for the elucidation of the immunologic correlates that underlie control of AIDS virus replication. We discuss the importance of major histocompatibility complex class I (MHC-I) alleles in activating CD8+ T-cell populations that promote control of both HIV and simian immunodeficiency virus (SIV) replication. Provocatively, we make the argument that T-cell subsets recognizing the HIV/SIV viral infectivity factor (Vif) protein may be crucial for control of viral replication. We hope that this review demonstrates how an in-depth understanding of the MHC-I gene products associated with elite control of HIV/SIV, and the epitopes that they present, can provide researchers with a glimpse into the protective immune responses that underlie AIDS nonprogression.

KW - Cytotoxic T lymphocyte (CTL)

KW - Human immunodeficiency virus (HIV)

KW - Major histocompatibility complex (MHC)

KW - Nonhuman primate (NHP) model for AIDS

KW - Simian immunodeficiency virus (SIV)

UR - http://www.scopus.com/inward/record.url?scp=85022200772&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85022200772&partnerID=8YFLogxK

U2 - 10.1007/s00251-017-0997-3

DO - 10.1007/s00251-017-0997-3

M3 - Review article

C2 - 28695289

AN - SCOPUS:85022200772

VL - 69

SP - 511

EP - 519

JO - Immunogenetics

JF - Immunogenetics

SN - 0093-7711

IS - 8-9

ER -